We note that our mechanistic studies were performed in HeLa cells; validation in primary cervical cancer cells and patient-derived models will be essential to generalize IMP3’s impact on lipid metabolism and clinical outcome. This evidence concerns the gene IMP3 and cervical carcinoma.